Rockwell Medical (NASDAQ:RMTI) announced the promotion of Jesse Neri to chief financial officer (CFO).
Mr. Neri, formally Rockwell’s senior vice president of finance, joined the company in 2023, bringing more than 25 years of experience leading finance functions at public and private companies. Before joining Rockwell, Mr. Neri served as executive director of finance at Hemavant Sciences and Aruvant Sciences, both clinical-stage biopharmaceutical companies in the Roivant portfolio, focused on developing therapeutics that improve the lives of patients with blood disorders and hematological malignancies.
“Over the past year, Jesse has been instrumental in strengthening Rockwell’s financial infrastructure, reshaping our financial strategy, and developing a stronger public company financial organization and presence within the investor community,” said Mark Strobeck, Ph.D., president and CEO of Rockwell. “His promotion to CFO is a testament to his invaluable contributions and leadership within Rockwell and underscores our focus on driving long-term strategic growth and exercising strong fiscal discipline.”
